Drug class in one race
IL-6 receptor drugs for Rheumatoid Arthritis
3 tracked IL-6 receptor drugs in the Rheumatoid Arthritis race. The class explanation lives on the IL-6 receptor page; the full indication pipeline across every mechanism is on the Rheumatoid Arthritis page.
2 approved / phase 41 Phase 3
Head-to-head evidence: Levilimab vs Sarilumab · Levilimab vs tocilizumab · Sarilumab vs tocilizumab